Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Majoven XL 37.5mg capsules
0403040W0CFAAAS
|
Majoven | Venlafaxine | Central Nervous System | No data available |
|
Mentaven XL 150mg capsules
0403040W0BUABAE
|
Mentaven | Venlafaxine | Central Nervous System | No data available |
|
Mentaven XL 75mg capsules
0403040W0BUAAAD
|
Mentaven | Venlafaxine | Central Nervous System | No data available |
|
Ranfaxine XL 75mg capsules
0403040W0BQAAAD
|
Ranfaxine | Venlafaxine | Central Nervous System | No data available |
|
Rodomel XL 150mg capsules
0403040W0BCABAE
|
Rodomel | Venlafaxine | Central Nervous System | No data available |
|
Tardcaps XL 150mg capsules
0403040W0BFABAE
|
Tardcaps | Venlafaxine | Central Nervous System | No data available |
|
Tardcaps XL 75mg capsules
0403040W0BFAAAD
|
Tardcaps | Venlafaxine | Central Nervous System | No data available |
|
Tifaxin XL 150mg capsules
0403040W0BJABAE
|
Tifaxin | Venlafaxine | Central Nervous System | No data available |
|
Tifaxin XL 75mg capsules
0403040W0BJAAAD
|
Tifaxin | Venlafaxine | Central Nervous System | No data available |
|
Trixat XL 150mg capsules
0403040W0BDABAE
|
Trixat | Venlafaxine | Central Nervous System | No data available |
|
Trixat XL 75mg capsules
0403040W0BDAAAD
|
Trixat | Venlafaxine | Central Nervous System | No data available |
|
Vaxalin XL 150mg capsules
0403040W0BKABAE
|
Vaxalin | Venlafaxine | Central Nervous System | No data available |
|
Vaxalin XL 75mg capsules
0403040W0BKAAAD
|
Vaxalin | Venlafaxine | Central Nervous System | No data available |
|
Venlafaxine 150mg oral powder sachets
0403040W0AAAHAH
|
Venlafaxine | Venlafaxine | Central Nervous System | No data available |
|
Venlafaxine 150mg/5ml oral liquid
0403040W0AAAIAI
|
Venlafaxine | Venlafaxine | Central Nervous System | No data available |
|
Venlafaxine 225mg/5ml oral suspension
0403040W0AAAUAU
|
Venlafaxine | Venlafaxine | Central Nervous System | No data available |
|
Venlafaxine 50mg tablets
0403040W0AAACAC
|
Venlafaxine | Venlafaxine | Central Nervous System | No data available |
|
Venlaneo XL 150mg capsules
0403040W0BWABAE
|
Venlaneo | Venlafaxine | Central Nervous System | No data available |
|
Vexarin XL 150mg capsules
0403040W0BHABAE
|
Vexarin | Venlafaxine | Central Nervous System | No data available |
|
Vexarin XL 75mg capsules
0403040W0BHAAAD
|
Vexarin | Venlafaxine | Central Nervous System | No data available |
|
ViePax 37.5mg tablets
0403040W0BIACAA
|
Viepax | Venlafaxine | Central Nervous System | No data available |
|
Winfex XL 150mg capsules
0403040W0BEABAE
|
Winfex | Venlafaxine | Central Nervous System | No data available |
|
Winfex XL 75mg capsules
0403040W0BEAAAD
|
Winfex | Venlafaxine | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.